Cardiac Tumours AND Systemic Manifestations OF Cardiac Disease — Written Clinical Reasoning · Phys Written Answers

Prompt

DCE-style written reasoning for Cardiac Tumours AND Systemic Manifestations OF Cardiac Disease.

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Cardiac Tumours AND Systemic Manifestations OF Cardiac Disease and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Chen Z, Zheng M, Li Y, Zhang X, et al. Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicity: Mechanisms, Clinical Manifestations, and Clinical Impact Cardiovasc Toxicol, 2026.PMID 42162235
[2]Kebede LM, Woldeamanuel AM, Mehammed FM, Girma HG, et al. Unmasking multiple myeloma first presentation as pericardial effusion with tamponade physiology: a case report J Med Case Rep, 2026.PMID 41549254
[3]Pálla S, Metyovinyi Z, Meznerics FA, Mirzahosseini A, et al. Dermatologic Features of Endocrine Tumor Syndromes-Systematic Review and Meta-Analysis Int J Dermatol, 2026.PMID 41165034
[4]Wasserman JD, Schneider KW, Achatz MI, Nakano Y, et al. Updated Recommendations for Pediatric Surveillance in Hereditary Endocrine Neoplasia Syndromes: Multiple Endocrine Neoplasias, Hyperparathyroidism-Jaw Tumor Syndrome, and Carney Complex Clin Cancer Res, 2025.PMID 40560659
[5]Schmitz KH, Prosnitz RG, Schwartz AL, Carver JR Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors Cancer, 2012.PMID 22488701
[6]Yoneda S, Koyama M, Matsubara T, Toyama S Electrocardiographic studies in acute pericarditis with specific reference to ventricular involvement of non-specific pericarditis Acta Cardiol, 1977.PMID 304653
[7]Doan HN, Chang MC Comparative Effectiveness of Unstable Versus Stable Resistance Training on Lower Limb Strength, Mobility, and Fear of Falling in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials Am J Phys Med Rehabil, 2026.PMID 42468010
[8]Liu HW, Tsai TL Virtual Reality-assisted Physiotherapeutic Training for Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis Am J Phys Med Rehabil, 2026.PMID 42468005

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Cardiac Tumours AND Systemic Manifestations OF Cardiac Disease and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Chen Z, Zheng M, Li Y, Zhang X, et al. Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicity: Mechanisms, Clinical Manifestations, and Clinical Impact Cardiovasc Toxicol, 2026.PMID 42162235
[2]Kebede LM, Woldeamanuel AM, Mehammed FM, Girma HG, et al. Unmasking multiple myeloma first presentation as pericardial effusion with tamponade physiology: a case report J Med Case Rep, 2026.PMID 41549254
[3]Pálla S, Metyovinyi Z, Meznerics FA, Mirzahosseini A, et al. Dermatologic Features of Endocrine Tumor Syndromes-Systematic Review and Meta-Analysis Int J Dermatol, 2026.PMID 41165034
[4]Wasserman JD, Schneider KW, Achatz MI, Nakano Y, et al. Updated Recommendations for Pediatric Surveillance in Hereditary Endocrine Neoplasia Syndromes: Multiple Endocrine Neoplasias, Hyperparathyroidism-Jaw Tumor Syndrome, and Carney Complex Clin Cancer Res, 2025.PMID 40560659
[5]Schmitz KH, Prosnitz RG, Schwartz AL, Carver JR Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors Cancer, 2012.PMID 22488701
[6]Yoneda S, Koyama M, Matsubara T, Toyama S Electrocardiographic studies in acute pericarditis with specific reference to ventricular involvement of non-specific pericarditis Acta Cardiol, 1977.PMID 304653
[7]Doan HN, Chang MC Comparative Effectiveness of Unstable Versus Stable Resistance Training on Lower Limb Strength, Mobility, and Fear of Falling in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials Am J Phys Med Rehabil, 2026.PMID 42468010
[8]Liu HW, Tsai TL Virtual Reality-assisted Physiotherapeutic Training for Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis Am J Phys Med Rehabil, 2026.PMID 42468005